or Try an Advanced Search...

    Technical Analysis for VRCA - Verrica Pharmaceuticals Inc.

    Grade Last Price % Change Price Change
    B 9.10 -4.11% -0.39
    VRCA closed down 4.11 percent on Wednesday, May 15, 2024, on 1.35 times normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical VRCA trend table...
    Date Alert Name Type % Chg
    Slingshot Bullish Bullish Swing Setup 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Shooting Star Candlestick Bearish -4.11%
    Volume Surge Other -4.11%
    Wide Range Bar Range Expansion -4.11%
    New 52 Week High Strength -4.11%
    Upper Bollinger Band Walk Strength -4.11%
    Older End-of-Day Signals for VRCA ...

       Recent Intraday Alerts

    Alert Time
    Up 3% about 21 hours ago
    Shooting Star Candlestick Entry about 21 hours ago
    Fell Below Previous Day's Low about 21 hours ago
    Down 2 % about 21 hours ago
    Down 1% about 21 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    VRCA Chart by TradingView
    Basic chart:

    Profile

    Verrica is a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs. The company’s lead product candidate, VP-102, is currently being evaluated in two Phase 3 clinical trials for the treatment of molluscum and in a Phase 2 clinical trial for the treatment of common warts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Medication Pharmaceutical Products Clinical Trial Skin Diseases Treatment Of Skin Diseases Common Warts

    Is VRCA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 15 Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts
    May 14 Verrica Pharmaceuticals Inc (VRCA) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
    May 13 Verrica Pharmaceuticals, Inc. (VRCA) Q1 2024 Earnings Call Transcript
    May 13 Verrica Pharmaceuticals Inc (VRCA) Reports Q1 2024 Results: A Detailed Financial Review
    May 13 Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates
    May 13 Verrica Pharmaceuticals Non-GAAP EPS of -$0.38 beats by $0.06, revenue of $3.83M beats by $1.18M
    May 13 Verrica Pharmaceuticals Reports First Quarter 2024 Financial Results
    May 9 Verrica Pharmaceuticals to Present at Upcoming Investor Conferences
    May 8 Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024
    May 6 Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last?
    See more VRCA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.4
    52 Week Low 2.86
    Average Volume 198,384
    200-Day Moving Average 5.13
    50-Day Moving Average 6.46
    20-Day Moving Average 7.47
    10-Day Moving Average 8.06
    Average True Range 0.63
    RSI (14) 74.09
    ADX 47.29
    +DI 49.16
    -DI 8.95
    Chandelier Exit (Long, 3 ATRs) 9.50
    Chandelier Exit (Short, 3 ATRs) 8.44
    Upper Bollinger Bands 9.25
    Lower Bollinger Band 5.69
    Percent B (%b) 0.96
    BandWidth 47.60
    MACD Line 0.68
    MACD Signal Line 0.48
    MACD Histogram 0.2038
    Fundamentals Value
    Market Cap 382.79 Million
    Num Shares 42.1 Million
    EPS -1.08
    Price-to-Earnings (P/E) Ratio -8.43
    Price-to-Sales 72.34
    Price-to-Book 5.47
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 10.66
    Resistance 3 (R3) 10.77 10.36 10.40
    Resistance 2 (R2) 10.36 9.96 10.30 10.31
    Resistance 1 (R1) 9.73 9.72 9.52 9.62 10.23
    Pivot Point 9.32 9.32 9.22 9.26 9.32
    Support 1 (S1) 8.69 8.92 8.49 8.58 7.97
    Support 2 (S2) 8.28 8.68 8.23 7.89
    Support 3 (S3) 7.65 8.28 7.80
    Support 4 (S4) 7.54